# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 169


In regulation 213 (amendment of regulation 281 (duties of authorisation holders and registration holders)) for paragraphs (b) and (c) substitute—
“(b) omit “or” at the end of sub-paragraph (c); and
(c) in sub-paragraph (d), after “for a medicinal product” insert—
“; or
(e) an EU marketing authorisation for a medicinal product.”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/169 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-169
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.